Files
Abstract
Diabetes remains a major clinical and financial burden in the United States, with many individuals—particularly those with public insurance—experiencing poor disease control and preventable complications. This study compared outcomes between a chronic illness management (CIM) care model and a traditional general internal medicine (GIM) model, examining whether insurance status influences blood glucose control. Using a retrospective cohort of 662 adults with diabetes, HbA1c outcomes were analyzed over an average 335‑day follow‑up. Logistic and linear regression models assessed the effects of insurance type, care model, and their interaction. The study evaluated whether the CIM model offers equal benefit across insurance groups and how insurance status relates to glycemic control.